1. Home
  2. INSM vs PINS Comparison

INSM vs PINS Comparison

Compare INSM & PINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSM
  • PINS
  • Stock Information
  • Founded
  • INSM 1988
  • PINS 2008
  • Country
  • INSM United States
  • PINS United States
  • Employees
  • INSM N/A
  • PINS N/A
  • Industry
  • INSM Biotechnology: Pharmaceutical Preparations
  • PINS Computer Software: Programming Data Processing
  • Sector
  • INSM Health Care
  • PINS Technology
  • Exchange
  • INSM Nasdaq
  • PINS Nasdaq
  • Market Cap
  • INSM 26.0B
  • PINS 23.8B
  • IPO Year
  • INSM 2000
  • PINS 2019
  • Fundamental
  • Price
  • INSM $127.80
  • PINS $35.81
  • Analyst Decision
  • INSM Strong Buy
  • PINS Strong Buy
  • Analyst Count
  • INSM 17
  • PINS 28
  • Target Price
  • INSM $137.40
  • PINS $42.74
  • AVG Volume (30 Days)
  • INSM 3.0M
  • PINS 12.0M
  • Earning Date
  • INSM 08-07-2025
  • PINS 08-07-2025
  • Dividend Yield
  • INSM N/A
  • PINS N/A
  • EPS Growth
  • INSM N/A
  • PINS 865.81
  • EPS
  • INSM N/A
  • PINS 2.74
  • Revenue
  • INSM $398,105,000.00
  • PINS $3,905,718,000.00
  • Revenue This Year
  • INSM $28.23
  • PINS $16.81
  • Revenue Next Year
  • INSM $119.99
  • PINS $15.87
  • P/E Ratio
  • INSM N/A
  • PINS $13.05
  • Revenue Growth
  • INSM 21.15
  • PINS 17.00
  • 52 Week Low
  • INSM $60.40
  • PINS $23.68
  • 52 Week High
  • INSM $128.48
  • PINS $40.90
  • Technical
  • Relative Strength Index (RSI)
  • INSM 85.01
  • PINS 45.32
  • Support Level
  • INSM $106.54
  • PINS $33.91
  • Resistance Level
  • INSM $128.48
  • PINS $39.83
  • Average True Range (ATR)
  • INSM 4.11
  • PINS 1.23
  • MACD
  • INSM 1.68
  • PINS -0.42
  • Stochastic Oscillator
  • INSM 97.41
  • PINS 39.68

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

About PINS Pinterest Inc.

Pinterest is a social media platform with a focus on product and idea discovery. Pinterest users, or pinners, can leverage the platform as they go about gathering ideas on topics such as home improvement, fashion, cooking, and travel. The company has more than 500 million monthly active users, two thirds of whom are female. Pinterest generates revenue by selling digital ads on its platform. While the platform's user base spans the globe, the vast majority of its revenue stems from ads shown to North American users.

Share on Social Networks: